馬光-KY

0.00 (0.00%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

41.0025成交張數–本益比4.50股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	13	4	66.4%	0.62	9.12	-24.1%	-7.6%	0.3	0.3
2026Q1	13	4	65.7%	0.50	9.43	-18.0%	-5.7%	0.2	0.2
2025Q4	14	4	65.5%	0.57	9.82	-14.9%	-4.8%	0.9	0.8
2025Q3	13	5	62.7%	0.56	10.63	-1.4%	-0.4%	0.5	0.4
2025Q2	14	4	65.0%	0.57	10.25	4.7%	1.4%	0.9	0.8
2025Q1	15	5	66.2%	0.57	10.62	5.1%	1.5%	0.2	0.1
2024Q4	14	5	64.1%	0.57	10.78	2.4%	0.7%	1.0	1.0
2024Q3	14	4	66.3%	0.57	10.08	-4.6%	-1.3%	0.8	0.7
2024Q2	15	4	68.4%	0.62	9.56	-14.0%	-4.0%	1.2	1.1
2024Q1	15	4	70.4%	0.65	9.16	-15.8%	-4.3%	0.4	0.4
2023Q4	16	4	70.1%	0.72	9.60	-10.1%	-2.7%	0.9	0.8
2023Q3	16	4	69.4%	0.74	10.01	-11.7%	-3.3%	0.8	0.6
2023Q2	15	4	67.1%	0.80	10.33	-7.4%	-2.3%	0.2	0.2
2023Q1	15	4	68.2%	0.83	10.03	-7.5%	-2.3%	0.1	0.1
2022Q4	16	4	68.5%	0.80	10.11	-6.9%	-2.1%	-0.0	-0.1
2022Q3	15	5	66.2%	0.78	10.84	4.3%	1.3%	1.2	0.3
2022Q2	14	5	61.5%	0.99	10.81	6.3%	2.3%	0.0	-0.1
2022Q1	14	5	60.5%	1.00	11.21	6.3%	2.3%	0.7	0.4
2021Q4	13	5	60.7%	0.79	10.95	7.4%	2.8%	0.7	0.5
2021Q3	13	4	63.7%	0.79	9.84	11.6%	4.1%	1.2	1.2
2021Q2	14	6	53.8%	1.12	13.13	11.7%	4.5%	0.4	0.2
2021Q1	14	6	53.8%	1.21	13.20	15.4%	6.0%	0.1	0.0
2020Q4	14	6	52.8%	1.05	13.39	14.0%	5.5%	1.3	1.2
2020Q3	13	5	54.0%	0.96	12.20	26.8%	9.9%	0.8	0.8
2020Q2	13	5	56.6%	0.80	11.62	25.0%	9.0%	0.7	0.7
2020Q1	13	5	56.3%	0.93	12.27	18.4%	6.6%	0.1	0.1
2019Q4	14	5	56.8%	0.92	12.63	13.3%	5.4%	0.4	0.4
2019Q3	13	5	61.7%	0.84	10.76	-0.3%	-0.1%	0.2	0.1
2019Q2	14	5	61.8%	0.78	11.02	3.9%	1.5%	0.3	0.2
2019Q1	14	5	61.9%	0.76	10.85	2.5%	0.9%	0.1	0.1
2018Q4	11	5	50.3%	1.02	11.54	5.8%	2.5%	0.2	0.2
2018Q3	11	5	50.9%	0.93	10.95	7.6%	3.3%	0.3	0.3
2018Q2	11	4	50.9%	0.93	11.69	4.5%	1.9%	0.2	0.1
2018Q1	10	5	48.1%	1.26	11.93	8.5%	3.6%	0.0	-0.0
2017Q4	11	5	50.7%	1.28	11.96	9.6%	3.9%	0.6	0.6
2017Q3	10	4	49.3%	1.25	11.29	0.1%	0.0%	0.1	0.1
2017Q2	10	4	50.2%	1.27	10.95	-4.5%	-1.9%	-0.0	-0.0
2017Q1	10	4	51.8%	1.13	10.60	-10.1%	-4.1%	-0.0	-0.0
2016Q4	11	4	54.9%	1.02	10.84	–	–	1.2	1.1
2016Q3	11	4	52.6%	1.08	11.41	–	–	0.6	0.5